ArticleLancet regional health. Americas2025
The cost of inaction to strengthen the resilience of primary health care in Latin America and the Caribbean: a modelling study.
Article in Lancet regional health. Americas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Manifesto for Universal Healthcare: Reconstituting Primary Care Through Digital Innovation, Microbial Technologies and Empowered Citizenship.Microbial biotechnology · 2026Article
- Factors associated with contraceptive use among reproductive-age women during a pandemic: Evidence from a small developing state.PLOS global public health · 2026Article
- No time to wait: resilience as a cornerstone for primary health care across Latin America and the Caribbean, a World Bank-PAHO Lancet Regional Health Americas Commission.Lancet regional health. Americas · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Latin America and the Caribbean (LAC) region will face future public health emergencies due to pandemics, natural disasters, migration, economic crisis or other unforeseen events. These events disrupt healthcare service coverage with consequences for morbidity, mortality and economic productivity. This study aimed to estimate the health and economic cost of potential future health system shocks, as a proxy for the cost of inaction to strengthen the resilience of primary health care. Methods: For 33 countries in LAC, primary health care shock scenarios were modelled as short-term reductions to the coverage of antenatal care and child health interventions using the Lives Saved Tool, and to family planning services and non-communicable disease management using custom models. Primary health care shocks starting in 2026 and leading to 25-50% relative coverage reductions (50% being a COVID-19-like disruption) with recovery periods of one to five years were compared to a strengthened primary health care scenario with intervention coverage maintained. Excess deaths and unintended pregnancies were estimated for 2026-2030 and converted to lifetime societal economic costs with 3% per annum discounting based on years of life lost (deaths) and reduced workforce productivity (unintended pregnancies). Findings: Depending on the magnitude and recovery time, the modelled primary health care shocks resulted in an additional 600-3100 stillbirths, 300-1400 neonatal deaths, 2000-10,000 child deaths, 2200-11,300 maternal deaths, 29,000-149,000 non-communicable disease deaths, and 2.7-14.1 million unintended pregnancies over 2026-2030. This translates to US$7-37 billion in societal economic costs per primary health care shock. Interpretation: Substantive investment in primary health care resilience would be warranted to limit the potential impact of health system shocks on service coverage. Funding: The World Bank.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.